Pure Global AI
NCT06398041Not yet recruiting

Feasibility BFRT Geriatric Stroke Patients

Feasibility of Blood Flow Restriction Training in Stroke Patients on a Geriatric Ward
Universitaire Ziekenhuizen KU LeuvenClinicalTrials.govother
Study focus
Disease/Condition
Stroke
Drug/Device/Intervention
Blood flow restriction training
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Universitaire Ziekenhuizen KU Leuven
Location
Pellenberg, Belgium
Timeline & enrollment
Phase
N/A
Start date
May 01, 2024
End date
Oct 01, 2025
Enrollment
16 participants
Primary outcome

Proportion of eligible individuals and their willingness to undergo BFRT,Prevalence and types of Adverse events,Rate of attended sessions over the total number of sessions planned,Visual Analog Scale for feelings of perceived pain, effort, safety and comfort,Time investment,Feasibility assessed by the physiotherapist,Feasibility assessed by the patients

Summary

The focus of this interventional study is to assess the feasibility of blood flow restriction
 training (BFRT) in a geriatric stroke population. Patients will undergo a 4-week program of
 BFRT additionally to our standard physiotherapy, conducted twice weekly by experienced
 physiotherapists.
 
 The main goal of the study is to assess its feasibility concerning the safety and tolerance
 of BFRT from a patients and therapists scope. Furthermore, the investigators want to
 establish the proportion of eligible individuals & their willingness to undergo BFRT, as well
 as the time investment.
 
 The feasibility of an effectiveness study and potential sample size will be evaluated aside.

ICD-10 classifications
Stroke, not specified as haemorrhage or infarctionSequelae of stroke, not specified as haemorrhage or infarctionCerebral infarctionFamily history of strokeCerebral infarction, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06398041
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06398041 through Pure Global AI's free database. This phase not specified trial is sponsored by Universitaire Ziekenhuizen KU Leuven and is currently Not yet recruiting. The study focuses on Stroke. Target enrollment is 16 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.